NRX Pharmaceuticals, Inc. Cash and Restricted Cash
NRX Pharmaceuticals, Inc. (NRXP) had Cash and Restricted Cash of $1.32 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-05-14
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.32M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.59M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.90M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.97M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.59M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $8.90M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $14.97M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $16.51M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $20.05M 10-Q · filed 2024-05-14 | |
| 2022-09-30 | $18.25M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $24.55M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $40.20M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $27.61M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $38.88M 10-Q · filed 2022-11-14 | $38.88M 10-Q/A · filed 2022-08-12 |
| 2021-06-30 | $13.39M 10-Q · filed 2022-08-15 | $13.39M 10-Q/A · filed 2022-08-12 |
| 2021-03-31 | $13.27M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $1.86M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $1.29M 10-Q/A · filed 2022-08-12 | |
| 2020-06-30 | $995.99K 10-Q/A · filed 2022-08-12 | |
| 2019-12-31 | $877.42K 10-Q/A · filed 2022-08-12 | $877.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |